Post-earnings recap
Reported
Mon, May 5, 2025
EPS actual
$-0.66
EPS est.
$-0.56
EPS surprise
-17.86%
1-day move
-8.44%
Twist Bioscience's earnings report indicates ongoing challenges, particularly reflected in the EPS miss. The stock fell 8.44% in response, suggesting investor disappointment. The lack of revenue figures and guidance adds uncertainty about the company's near-term outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.66 | N/A | -17.86% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about the current market conditions impacting performance. They highlighted a commitment to long-term strategies without providing specific guidance.
Management acknowledged the challenges faced in the quarter.
They emphasized a focus on long-term growth despite current setbacks.
There were no specific plans shared for future performance improvements.
Est. EPS
—
Est. Rev
—
Impl. Move
—